通过高度广泛和强大的中和抗体限制HIV-1逃逸
Philipp Schommers1, Henning Gruell2, Morgan E Abernathy3
1Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany; German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany.
Cell
|February 1, 2020
概括
一种新的广泛中和抗体 (bNAb) 1-18 显示出对HIV-1 的高强度和广度. 这种抗体有效地克服了小鼠的病毒逃逸和完全抑制的病毒病,提供了一个有前途的新HIV-1预防和治疗策略.
科学领域:
- 免疫学
- 病毒学
- 结构生物学
背景情况:
- 广泛中和抗体 (bNAbs) 对于预防和治疗HIV-1至关重要.
- 艾滋病毒-1包膜糖蛋白 (Env) 突变导致病毒逃逸,限制了bNAb的疗效.
- CD4结合部位 (CD4bs) bNAbs是主要的目标,但耐药性仍然是一个挑战.
研究的目的:
- 描述一种新的CD4bsbNAb,1-18,其宽度,功效和对HIV-1逃逸的抵抗力.
- 研究1-18对抗抗性HIV-1变体的有效性背后的机制.
- 在临床前模型中评估1-18的治疗潜力.
主要方法:
- 对bNAb 1-18的结合范围和强度 (IC50) 对各种HIV-1分离物的表征.
- 对常见的CD4bs脱离突变的1-18活动的评估.
- 突变抗原分析以确定HIV-1逃生途径.
- 在HIV-1感染的人类化小鼠体内疗效研究.
- 用冷电子显微镜 (cryo-EM) 确定1-18-Env复合物的结构.
主要成果:
- 1-18 具有97%的宽度和高强度 (地质平均IC50=0. 048μg/ ml) 对抗HIV-1.
- 对典型的CD4bs脱离突变有效,并克服对其他CD4bsbNAbs的抵抗.
- 突变分析显示HIV-1的逃生途径受到限制.
- 在没有选择耐药变种的人性化小鼠中,单独使用1-18完全抑制了病毒性.
- 化EM结构显示重链插入和增加的原体间接触有助于1-18的特性.
结论:
- 这种抗体具有对HIV-1的独特抗药性.
- 抗体的结构特征可能有助于限制病毒逃逸的能力.
- 由于其有效性和克服耐药性的能力,该药物是HIV-1预防和治疗的有希望的治疗候选药物.
相关概念视频
Retrovirus Life Cycles
49.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.0K
Immune Response Against Viral Pathogens
1.6K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.6K


